Cargando…
The molecular mechanism of RIG‐I activation and signaling
RIG‐I is our first line of defense against RNA viruses, serving as a pattern recognition receptor that identifies molecular features common among dsRNA and ssRNA viral pathogens. RIG‐I is maintained in an inactive conformation as it samples the cellular space for pathogenic RNAs. Upon encounter with...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293153/ https://www.ncbi.nlm.nih.gov/pubmed/34514601 http://dx.doi.org/10.1111/imr.13022 |
_version_ | 1784749551667642368 |
---|---|
author | Thoresen, Daniel Wang, Wenshuai Galls, Drew Guo, Rong Xu, Ling Pyle, Anna Marie |
author_facet | Thoresen, Daniel Wang, Wenshuai Galls, Drew Guo, Rong Xu, Ling Pyle, Anna Marie |
author_sort | Thoresen, Daniel |
collection | PubMed |
description | RIG‐I is our first line of defense against RNA viruses, serving as a pattern recognition receptor that identifies molecular features common among dsRNA and ssRNA viral pathogens. RIG‐I is maintained in an inactive conformation as it samples the cellular space for pathogenic RNAs. Upon encounter with the triphosphorylated terminus of blunt‐ended viral RNA duplexes, the receptor changes conformation and releases a pair of signaling domains (CARDs) that are selectively modified and interact with an adapter protein (MAVS), thereby triggering a signaling cascade that stimulates transcription of interferons. Here, we describe the structural determinants for specific RIG‐I activation by viral RNA, and we describe the strategies by which RIG‐I remains inactivated in the presence of host RNAs. From the initial RNA triggering event to the final stages of interferon expression, we describe the experimental evidence underpinning our working knowledge of RIG‐I signaling. We draw parallels with behavior of related proteins MDA5 and LGP2, describing evolutionary implications of their collective surveillance of the cell. We conclude by describing the cell biology and immunological investigations that will be needed to accurately describe the role of RIG‐I in innate immunity and to provide the necessary foundation for pharmacological manipulation of this important receptor. |
format | Online Article Text |
id | pubmed-9293153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92931532022-07-20 The molecular mechanism of RIG‐I activation and signaling Thoresen, Daniel Wang, Wenshuai Galls, Drew Guo, Rong Xu, Ling Pyle, Anna Marie Immunol Rev Invited Reviews RIG‐I is our first line of defense against RNA viruses, serving as a pattern recognition receptor that identifies molecular features common among dsRNA and ssRNA viral pathogens. RIG‐I is maintained in an inactive conformation as it samples the cellular space for pathogenic RNAs. Upon encounter with the triphosphorylated terminus of blunt‐ended viral RNA duplexes, the receptor changes conformation and releases a pair of signaling domains (CARDs) that are selectively modified and interact with an adapter protein (MAVS), thereby triggering a signaling cascade that stimulates transcription of interferons. Here, we describe the structural determinants for specific RIG‐I activation by viral RNA, and we describe the strategies by which RIG‐I remains inactivated in the presence of host RNAs. From the initial RNA triggering event to the final stages of interferon expression, we describe the experimental evidence underpinning our working knowledge of RIG‐I signaling. We draw parallels with behavior of related proteins MDA5 and LGP2, describing evolutionary implications of their collective surveillance of the cell. We conclude by describing the cell biology and immunological investigations that will be needed to accurately describe the role of RIG‐I in innate immunity and to provide the necessary foundation for pharmacological manipulation of this important receptor. John Wiley and Sons Inc. 2021-09-12 2021-11 /pmc/articles/PMC9293153/ /pubmed/34514601 http://dx.doi.org/10.1111/imr.13022 Text en © 2021 The Authors. Immunological Reviews published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Invited Reviews Thoresen, Daniel Wang, Wenshuai Galls, Drew Guo, Rong Xu, Ling Pyle, Anna Marie The molecular mechanism of RIG‐I activation and signaling |
title | The molecular mechanism of RIG‐I activation and signaling |
title_full | The molecular mechanism of RIG‐I activation and signaling |
title_fullStr | The molecular mechanism of RIG‐I activation and signaling |
title_full_unstemmed | The molecular mechanism of RIG‐I activation and signaling |
title_short | The molecular mechanism of RIG‐I activation and signaling |
title_sort | molecular mechanism of rig‐i activation and signaling |
topic | Invited Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293153/ https://www.ncbi.nlm.nih.gov/pubmed/34514601 http://dx.doi.org/10.1111/imr.13022 |
work_keys_str_mv | AT thoresendaniel themolecularmechanismofrigiactivationandsignaling AT wangwenshuai themolecularmechanismofrigiactivationandsignaling AT gallsdrew themolecularmechanismofrigiactivationandsignaling AT guorong themolecularmechanismofrigiactivationandsignaling AT xuling themolecularmechanismofrigiactivationandsignaling AT pyleannamarie themolecularmechanismofrigiactivationandsignaling AT thoresendaniel molecularmechanismofrigiactivationandsignaling AT wangwenshuai molecularmechanismofrigiactivationandsignaling AT gallsdrew molecularmechanismofrigiactivationandsignaling AT guorong molecularmechanismofrigiactivationandsignaling AT xuling molecularmechanismofrigiactivationandsignaling AT pyleannamarie molecularmechanismofrigiactivationandsignaling |